Clinical trials
Adult clinical trials
Below are recruiting adult clinical trials, each written for real people, not researchers. We’re tracking 3,740 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06808828Recruiting
Occupational therapy for survivors of partner violence
This trial tests if occupational therapy can help adults who have experienced intimate partner violence improve daily living skills and well-being. It is open to anyone 18 or older already getting help from a domestic violence organization.
Loma Linda, CaliforniaAges 18–70 - NCT06804109Recruiting
Nerve stimulation and cognition in young adults who vape
This study tests whether a gentle, non-invasive nerve stimulation device (placed on the neck) can affect thinking and attention in young adults who vape. You'd attend a single session where you receive the stimulation or a placebo while doing simple computer tasks.
Philadelphia, PennsylvaniaAges 18–25 - NCT06798298Recruiting
Long-term safety study of gene modified T cell treatment
This study is a long-term safety check for people who have already received a gene modified T cell treatment in a previous study sponsored by 2seventy bio or Regeneron Pharmaceuticals. The goal is to monitor your health for years after that treatment to see how well it works and if any side effects appear over time.
Nashville, TennesseeAges 18 years+ - NCT06763172RecruitingPhase 4
Caffeine's effect on learning in healthy adults
This study uses brain scans to see how caffeine affects the way we learn from rewards and punishments. You may be eligible if you are a healthy adult who drinks a moderate amount of caffeine daily.
Charlestown, MassachusettsAges 18–45 - NCT06727695Recruiting
BioStrength training for muscle strength and satisfaction
This study tests a special strength training program called BioStrength to see if it improves muscle strength and overall satisfaction in healthy adults. The program lasts 12 weeks and is for people who are new to strength training.
Leibnitz, Styria, StyriaAges 30–65 - NCT06727643Enrolling by invitation
Tape types for better core strength in young adults
This study compares two types of tape (flexible and rigid) applied to the back to see which one improves core muscle strength more in healthy young adults. It's a short-term test to help understand how tape might support better movement or exercise.
Kırşehir, CentreAges 18–25 - NCT06538766Recruiting
How focus instructions affect strength training and walking in older adults
This study tests whether different types of mental focus during strength training can improve walking ability in older adults. It may help find better ways to stay steady and prevent falls.
Monte de Caparica, AlmadaAges 18 years+ - NCT06041048RecruitingPhase 4
Study on brain function and attention in healthy adults
This study looks at how a brain area called the locus coeruleus affects your ability to pay attention. It involves taking a medication called modafinil and having MRI scans to see how your brain works.
Sacramento, CaliforniaAges 18–60 - NCT04405115Recruiting
Help for older adults to get better cancer aftercare
This study aims to improve “survivorship care plans,” which are follow-up instructions after chemotherapy, to help older adults feel supported after cancer treatment. You may be able to participate if you’re 65+ and recently finished chemotherapy with the goal of cure and have a plan scheduled with an oncology navigator.
Clovis, CaliforniaAges 65 years+ - NCT01132859Recruiting
Study of how immune cells respond in adults
This study looks at how your body’s immune system reacts in different tissues by collecting and storing samples for research. You might be able to join if you’re an adult and can consent, and if you don’t have certain bleeding risks that could make sample collection unsafe.
Bethesda, MarylandAges 18–120 - NCT06486051RecruitingPhase 2
CAR T-cell therapy for adults with relapsed large B-cell lymphoma
This trial tests a new treatment called atlacabtagene autoleucel, which uses your own immune cells to fight the lymphoma. It's designed for people whose lymphoma has come back or not responded to initial treatments.
Auckland, AucklandAges 18–75 - NCT07751783Recruiting
Exercise program for cancer survivors
This trial helps people who have finished cancer treatment start a supervised exercise routine to improve their health. It tests whether a structured program with professional guidance is safe and helpful.
Kaohsiung, TaiwanAges 18–80 - NCT07751380RecruitingPhase 1
CAR T-cell therapy for children and young adults with certain sarcomas
This trial tests a new kind of cell therapy called CAR T-cells that are engineered to find and attack sarcoma cells carrying a marker called B7-H3. It is for children and young adults whose sarcoma has come back or not gone away after treatment.
LondonAges 1–24 - NCT05809284Recruiting
Understanding CAR T-cell therapy persistence in young patients with ALL
This study looks at why CAR T-cell therapy stops working in some children and young adults with leukemia. It aims to help doctors understand how to make this treatment last longer.
LondonAges Up to 25 years - NCT07752433Recruiting
Brain stimulation with augmented reality for lazy eye in adults
This trial tests a new treatment for adults with lazy eye (amblyopia) that combines brain stimulation with a special vision game using augmented reality. The goal is to improve vision in the weaker eye.
Porto, Porto DistrictAges 18–40 - NCT07291232RecruitingPhase 1
Study of an injected drug for adults with obesity
This study tests an injected medication called ABBV-295 for adults with obesity. The goal is to see how safe it is and how the body processes it. You may join if you have a BMI between 30 and 45 and are generally healthy, and you haven't been on other weight loss treatments recently.
Anaheim, CaliforniaAges 18–65 - NCT06638307RecruitingPhase 1
Study of new drug MEN2312 for advanced breast cancer with specific genetic changes
This trial tests a new drug, MEN2312, for people with advanced breast cancer that has specific genetic changes in PIK3CA, AKT1, or PTEN. It's for those who have already tried certain hormone therapies and a CDK4/6 inhibitor combination, and the cancer has continued to grow.
Springdale, ArkansasAges 18 years+ - NCT07479173Recruiting
How a study ingredient affects protein digestion in healthy adults
This trial tests whether a study ingredient called P24 changes how your body breaks down and uses protein from a meal. It may help researchers understand ways to support muscle health as we age.
Davis, CaliforniaAges 45–75 - NCT07502443RecruitingPhase 3
Study of ALKS 2680 for narcolepsy type 2
This study tests an investigational drug called ALKS 2680 for people with narcolepsy type 2, a condition that causes excessive daytime sleepiness without sudden muscle weakness. The goal is to see if the drug is safe and helps reduce daytime sleepiness.
Cullman, AlabamaAges 18–70 - NCT07532785Recruiting
Water and Land Exercise Before Knee Replacement Surgery
This trial tests whether a 6-week program combining weekly water-based exercise and three times weekly land-based training can help reduce knee pain and improve strength before total knee replacement surgery. The program aims to help you recover better after your operation.
London, EnglandAges 18 years+ - NCT06980480RecruitingPhase 3
Gammagard to prevent infections in multiple myeloma
This study tests if adding Gammagard (a type of antibody therapy) to your multiple myeloma treatment with Tecvayli can help prevent serious infections. You may qualify if you recently started Tecvayli and are still responding to it.
Mobile, AlabamaAges 18 years+ - NCT06948318RecruitingPhase 3
Follow-up study of mezagitamab for chronic ITP
This study follows up with adults who completed a previous mezagitamab trial for chronic immune thrombocytopenia (ITP). It monitors long-term safety and effectiveness of the treatment.
Hot Springs, ArkansasAges 18 years+ - NCT06722235RecruitingPhase 3
Mezagitamab for chronic ITP that hasn't responded to standard treatments
This study tests a new medicine called mezagitamab for adults with chronic ITP (low platelets for at least a year) who have not responded well to standard treatments. It aims to see if mezagitamab can safely raise platelet counts.
Hot Springs, ArkansasAges 18 years+ - NCT07730450RecruitingPhase 4
COVID-19 vaccine study for healthy adults aged 18 to 64
This trial tests a COVID-19 vaccine in healthy adults to see how well it works. It may be an option if you are not at higher risk for severe COVID-19 and have not had COVID-19 in the past 6 months.
Walnut Creek, CaliforniaAges 18–64
Hear when a new Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for adult?
- Yes. Clin2 currently lists 3,740 recruiting adult studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a adult trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a adult trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.